Beyond THC and CBD: Minor Cannabinoids: Bonni Goldstein @medicinal.genomics
Beyond THC and CBD: Minor Cannabinoids: Bonni Goldstein  @medicinal.genomics
Uploaded August 2026 | Updated September 2026, 2 weeks ago
Dr. Bonni Goldstein (Goldstein Wellness) presents "Beyond THC and CBD: Minor Cannabinoids" at CannMed 2026, covering CBG, CBDA, CBN, pain management, and inflammation.

This session explores emerging research on lesser-known cannabinoids beyond THC and CBD, such as CBG, CBDA, and CBN. Clinicians will gain insight into their pharmacology, potential therapeutic applications, and the evolving clinical evidence supporting their use in pain management, inflammation, anxiety, nausea, and sleep disorders.

Dr. Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a leading cannabis medicine specialty practice, and the CEO of GoldsteinWellness.com.

This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.

This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
Beyond THC and CBD: Minor Cannabinoids: Bonni GoldsteinWhat single compound in the cannabis plant would you want to see studied?The Wild Side of Emerging Cannabinoids: THC-O Gummies and a Grand Theft Auto HallucinationApplying AI and Machine Learning to Medical Cannabis with Hemant Kumar Bid, PhDThrough the Eyes of a Patient: Integrating Story and Science to Demystify CHS - Dr. Codi PetersonWhat Inspired You to Investigate The Role of Cannabinoids in Prostate Cancer Treatment?Putting Cannabis Labs to the Test with Morgan KeeferBreeding for Better Solventless Extraction with Alisha Holloway, PhDWhat is Cannabinoid Hyperemesis Syndrome & Why Has Researching it been so difficult? - Codi PetersonCannabis Pangenome Exposes Minor Cannabinoid Pathway Potential - Todd Michael, PhDNursing Panel - CannMed 25 Innovation & Investment SummitWhat are the next steps or findings for you and your team to build off your research?
Medicinal Genomics |

Beyond THC and CBD: Minor Cannabinoids: Bonni Goldstein

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER